Paris: Sanofi has announced that it has entered into an agreement to acquire Vigil Neuroscience, Inc., a publicly traded ...

Australia's drug and therapeutic regulatory agency has approved the first drug for treatment of Alzheimer's disease, public ...

Researchers at the University of São Paulo (USP) in Brazil have succeeded in showing, in an animal model, that the process of ...

Alzheimer’s is a complex disease caused by many interacting factors. It’s possible the herpes virus could play a small role – ...

The first Alzheimer's blood test cleared by the Food and Drug Administration is poised to change the way doctors diagnose and ...

Whether traveling by car or by air, busy holiday weekends can bring anxiety, especially for those traveling with loved ones ...

Whether traveling by car or by air, busy holiday weekends can bring anxiety, especially for those traveling with loved ones ...

Police posted the update Tuesday afternoon, saying, "Mr. Cox was located after a passerby on Wedgefield Road spotted him and ...

Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...

Sanofi (NASDAQ:SNY) has announced a deal to acquire Vigil Neuroscience, a clinical-stage biotech company, for around $470 ...

TYLER, Texas (KLTV) - The Alzheimer’s Alliance of Smith County is holding their biennial Dementia Care Conference next Wednesday. The event will provide resources and community for caregivers ...

Sanofi has entered an agreement to acquire Vigil Neuroscience for approximately $470 million, adding a new investigational ...